Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/06/043487
CTRI/2022/06/043487
Not Yet Recruiting
N/A

Assessing prevalence and risk of lung morbidities including lung nodules and cancer using non-contrast CT among PLHIV in Pune, India - LMCS PLHIV

TREAT Asia amfAR The Foundation for AIDS Research through a grant from the US NIH0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified
Sponsor
TREAT Asia amfAR The Foundation for AIDS Research through a grant from the US NIH
Status
Not Yet Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
TREAT Asia amfAR The Foundation for AIDS Research through a grant from the US NIH

Eligibility Criteria

Inclusion Criteria

  • •a.Men, women, and transgender persons known to be PLHIV ââ?°Â¥18 years of age.
  • •(Note: Participants must be able to show proof that they are living with HIV, either by having a unique treatment number associated with the BJGMC\-SGH ART center or a government provided HIV treatment book. A separate HIV test will not be performed in the study)
  • •b.Willingness to undergo at least one chest NCCT.
  • •c.Ability of the participant to provide informed consent.
  • •(Note: Illiterate participants will be enrolled based on local regulatory policies, with appropriate provisions for informed consent)

Exclusion Criteria

  • •a.Unwillingness to undergo at least one chest NCCT.
  • •b.Having undergone a computed tomography (CT) of any part of the body, positron emission tomography (PET) or interventional radiology procedure (coronary angiography, angioplasty, etc.) within one year prior to the anticipated enrollment date.
  • •c.Men, women or transgender PLHIV with cognitive, hearing or language impairment.
  • •d.Men, women or transgender persons with unknown HIV status.
  • •e.Men, women or transgender PLHIV with a history of lung cancer or having received treatment for lung cancer in the past.
  • •f.Pregnant women.
  • •g.Inability/ Unwillingness to provide informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Evaluation of background lung disease as risk factors of the drug-related interstitial pneumonia induced by the lung cancer chemotherapy
JPRN-UMIN000026964agasaki University Hospital, Second Department of Internal Medicine214
Completed
N/A
Prevalence, Clinical Features and Lung Functions of Asthma in Thai Elderly PatientsAsthmaElderlyAsthmaElderly
TCTR20210319007Faculty of Medicine, Thammasat University1,600
Not Yet Recruiting
N/A
ung function in post covid
CTRI/2021/05/033518All India Institute of Medical Sciences
Recruiting
N/A
Prevalence of pulmonary embolism in acute exacerbation of COPD patients
CTRI/2019/11/022028nil
Completed
N/A
Influence of pulmonary complications on morbidity and mortality after liver resection- A retrospective analysis based on a liver surgery database of Dresden University Hospital, referring to the years 2013 - 2021.iver resection regardless of underlying diagnosis
DRKS00032303niversitätsklinikum Carl Gustav Carus Dresden an der TU Dresden, Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie1,118